We just received data on a new analyst forecast for $DDS. UBS gave a rating of 'Sell' for $DDS.
$DDS Analyst Ratings
Wall Street analysts have issued reports on $DDS in the last several months. We have seen 0 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Sell" rating on 05/16/2025
To track analyst ratings and price targets for $DDS, check out Quiver Quantitative's $DDS forecast page.
$DDS Insider Trading Activity
$DDS insiders have traded $DDS stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $DDS stock by insiders over the last 6 months:
- TOM W BOLIN (VICE PRESIDENT) sold 300 shares for an estimated $130,035
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$DDS Hedge Fund Activity
We have seen 129 institutional investors add shares of $DDS stock to their portfolio, and 126 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PACER ADVISORS, INC. removed 314,143 shares (-89.2%) from their portfolio in Q1 2025, for an estimated $112,504,032
- ALYESKA INVESTMENT GROUP, L.P. removed 265,078 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $94,932,384
- NEW VERNON CAPITAL HOLDINGS II LLC added 185,531 shares (+26618.5%) to their portfolio in Q1 2025, for an estimated $66,444,217
- FIRST TRUST ADVISORS LP added 122,736 shares (+150.1%) to their portfolio in Q1 2025, for an estimated $43,955,443
- VANGUARD GROUP INC removed 122,374 shares (-24.9%) from their portfolio in Q1 2025, for an estimated $43,825,800
- UBS GROUP AG removed 114,952 shares (-89.4%) from their portfolio in Q1 2025, for an estimated $41,167,759
- NEWPORT TRUST COMPANY, LLC removed 77,030 shares (-1.6%) from their portfolio in Q1 2025, for an estimated $27,586,753
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
